| Literature DB >> 24900835 |
Meryem Köse1, Kirsten Ritter1, Katharina Thiemke1, Michel Gillard2, Evi Kostenis3, Christa E Müller1.
Abstract
The recently described synthetic GPR17 agonist 2-carboxy-4,6-dichloro-1H-indole-3-propionic acid (1) was prepared in tritium-labeled form by catalytic hydrogenation of the corresponding propenoic acid derivative 8 with tritium gas. The radioligand [(3)H]PSB-12150 (9) was obtained with a specific activity of 17 Ci/mmol (629 GBq/mmol). It showed specific and saturable binding to a single binding site in membrane preparations from Chinese hamster ovary cells recombinantly expressing the human GPR17. A competition assay procedure was established, which allows the determination of ligand binding affinities.Entities:
Keywords: MDL29,951; montelukast; multiple sclerosis; nucleotide; orphan GPCR; pranlukast; radioligand
Year: 2014 PMID: 24900835 PMCID: PMC4027623 DOI: 10.1021/ml400399f
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345